COMMUNIQUÉS West-GlobeNewswire
-
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
08/10/2025 -
Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation
08/10/2025 -
Unyte Health Celebrates 10 Years as the Leader in Nervous System Regulation and Sound-Based Listening Therapies
08/10/2025 -
Protext Mobility, Inc. (OTC: TXTM) Announces New Member of Its Advisory Board
08/10/2025 -
Tessera Therapeutics Awarded up to $41.3 Million from ARPA-H to Advance In Vivo CAR-T Therapies
08/10/2025 -
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
08/10/2025 -
Channel Medsystems Appoints Healthcare Executive Skip Baldino to Board of Directors
08/10/2025 -
Medicare Now Reimbursing for EnteroTrack’s Esophageal String Test®, Expanding Access to Patients with Eosinophilic Esophagitis
08/10/2025 -
NewGen Establishes New Joint Venture Dedicated to Real Estate Development in UAE
08/10/2025 -
Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water
08/10/2025 -
Zarminali Pediatrics Welcomes New Chief Technology Officer to Advance Patient-Centric Connected Care Model
08/10/2025 -
SCIENTURE Holdings Announces Full Repayment and Conversion of Outstanding Debentures, Strengthening Balance Sheet
08/10/2025 -
Pluri Subsidiary Coffeesai and Instituto del Café de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico
08/10/2025 -
PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists
08/10/2025 -
Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
08/10/2025 -
Journey Medical Corporation to Participate in October 2025 Investor Conferences
08/10/2025 -
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting
08/10/2025 -
Sapu Nano Unveils First-in-Human Clinical Trial of Sapu-003 at 8th Australian Translational Breast Cancer Research Symposium
08/10/2025 -
Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device
08/10/2025
Pages